Target intelligence / Profile preview

Neuronal porosome

Molecular classification
Supramolecular lipoprotein complex, Secretory machinery, Presynaptic membrane complex
01

Overview

The neuronal porosome is a 15 nm cup-shaped supramolecular lipoprotein structure located at the presynaptic plasma membrane of neurons [5, 10]. It serves as the universal secretory portal where synaptic vesicles transiently dock and fuse to release neurotransmitters into the synaptic cleft via a "kiss-and-run" mechanism [10, 12]. The complex is composed of approximately 30-40 proteins, including SNAREs (such as SNAP-25 and Syntaxin-1A), ion channels (like P/Q-type calcium channels), and motor proteins that regulate the opening and closing of the fusion pore [5, 13]. In neurodegenerative conditions like Alzheimer's disease, the porosome is disrupted by toxic beta-amyloid (1-42) and the depletion of essential components, leading to synaptic failure and impaired neurotransmission [1, 11]. Therapeutic approaches being developed by companies like Porosome Therapeutics involve the reconstitution of functional wild-type porosomes into diseased neurons or the use of AI-designed decoy peptides to protect the complex from amyloid-induced damage [1, 6, 8]. These strategies aim to restore both the secretory and metabolic integrity of the neuron to reverse disease pathology [2, 9].

Other names
Secretory portalSecretory nanomachinePresynaptic porosomeSynaptic porosomeNeuronal porosome complex
02

Mechanism of action

Restoration of the neuronal secretory machinery through porosome reconstitution and metabolic reprogramming, combined with the neutralization of toxic beta-amyloid to prevent disruption of porosome protein-protein interactions [1, 2, 11].

03

Biological functions

NeurotransmissionNeurosecretionSynaptic vesicle docking and fusionRegulation of the fusion poreKiss-and-run secretion
04

Disease associations

Alzheimer's diseaseNeurodegenerative diseaseNeurosecretory disordersDementia
05

Safety considerations

Blood-brain barrier (BBB) penetration for large biologicsDelivery and stability of reconstituted complexesPotential immunogenicity of exogenous porosome componentsTissue-specific targeting requirements
06

Interacting drugs

Reconstituted neuronal porosome

4 more in the full profile.

07

Biomarkers

Tau protein (t-tau)SNAP-25Beta-amyloid 1-42

Beyond the preview

Go deeper on Neuronal porosome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal porosome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call